Latest Regulatory News

Kaili Resources has reported encouraging initial pXRF results from its latest aircore drilling campaign targeting rare earth elements in South Australia's Mallee Project. Full assay results are pending, setting the stage for expanded exploration.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.

Orthocell has secured a $3 million R&D tax refund, lifting its cash reserves to nearly $50 million and reinforcing its financial strength as it pushes commercialisation of its nerve repair product Remplir™ across key global markets.

IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.

Aeris Resources has withdrawn aspirational statements about extending mine life at its Tritton and Jaguar operations following its Peel Resources acquisition announcement, urging investors to exercise caution.

Solvar Limited reported a 5.8% rise in half-year NPAT to $20 million, driven by the sale of its New Zealand written-off loan book and expanded debt facilities. The company also announced a special dividend and outlined growth plans in commercial lending.

Solvar Limited reported a 5.8% rise in net profit for the half year ending December 2025, driven by strategic asset sales and expanded funding facilities. The company declared both interim and special dividends, signalling confidence despite ongoing regulatory challenges.

Cleo Diagnostics has chosen Bio-Techne’s next-generation Ella™ platform to enhance its ovarian cancer blood test, aiming for faster, more precise results and a streamlined path to FDA approval.

Nickel Industries has received a significant 60% increase in its 2026 nickel ore sales quota, positioning the company to capitalise on rising nickel prices and ramp up its next-generation processing projects.

Chariot Resources Ltd has voluntarily suspended trading on the ASX as it finalises a significant financing arrangement, with an announcement expected by 20 February 2026.

American West Metals has appointed a top Washington DC advisory firm to deepen US government engagement for its West Desert Project, aiming to establish the first domestic indium supply chain amid critical minerals supply risks.

Albright Metals has agreed to sell a significant portion of its Bryah Basin tenements to Catalyst Metals for $1 million cash plus $800,000 in shares, enabling a sharper focus on its Canadian gold and antimony projects.